Related references
Note: Only part of the references are listed.Safety and Efficacy of Rituximab in Systemic Lupus Erythematosus
Benjamin Terrier et al.
ARTHRITIS AND RHEUMATISM (2010)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Marginal Zone Precursor B Cells as Cellular Agents for Type I IFN-Promoted Antigen Transport in Autoimmunity
John H. Wang et al.
JOURNAL OF IMMUNOLOGY (2010)
IL-17 Activates the Canonical NF-κB Signaling Pathway in Autoimmune B Cells of BXD2 Mice To Upregulate the Expression of Regulators of G-Protein Signaling 16
Shutao Xie et al.
JOURNAL OF IMMUNOLOGY (2010)
B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers
Thinh Huy Tran et al.
NATURE IMMUNOLOGY (2010)
Walking the AID tightrope
Mieun Lee-Theilen et al.
NATURE IMMUNOLOGY (2010)
AID constrains germinal center size by rendering B cells susceptible to apoptosis
Ahmad Zaheen et al.
BLOOD (2009)
Anticytokine therapy impacting on B cells in autoimmune diseases
Capucine Daridon et al.
CURRENT OPINION IN RHEUMATOLOGY (2009)
Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis
Chuancang Jiang et al.
IMMUNOLOGY (2009)
Taking Advantage: High-Affinity B Cells in the Germinal Center Have Lower Death Rates, but Similar Rates of Division, Compared to Low-Affinity Cells
Shannon M. Anderson et al.
JOURNAL OF IMMUNOLOGY (2009)
Increased Expression of Activation-Induced Cytidine Deaminase is Associated with Anti-CCP and Rheumatoid Factor in Rheumatoid Arthritis
X. Xu et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Ectopic Lymphoid Structures Support Ongoing Production of Class-Switched Autoantibodies in Rheumatoid Synovium
Frances Humby et al.
PLOS MEDICINE (2009)
Peripheral B cell subsets
David Allman et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Activation-Induced Cytidine Deaminase Deficiency Causes Organ-Specific Autoimmune Disease
Koji Hase et al.
PLOS ONE (2008)
Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice
Hui-Chen Hsu et al.
NATURE IMMUNOLOGY (2008)
Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice
Chuancang Jiang et al.
JOURNAL OF IMMUNOLOGY (2007)
Overexpression of activation-induced cytidine deaminase in B cells is associated with production of highly pathogenic autoantibodies
Hui-Chen Hsu et al.
JOURNAL OF IMMUNOLOGY (2007)
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2006)
AID in somatic hypermutation and class switch recombination
S Longerich et al.
CURRENT OPINION IN IMMUNOLOGY (2006)
Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritis
MJ Leandro et al.
ARTHRITIS AND RHEUMATISM (2006)
Production of a novel class of polyreactive pathogenic autoantibodies in BXD2 mice causes glomerulonephritis and arthritis
HC Hsu et al.
ARTHRITIS AND RHEUMATISM (2006)
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays
QL Zhen et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation
U Basu et al.
NATURE (2005)
Blockade of lymphotoxin pathway exacerbates autoimmune arthritis by enhancing the Th1 response
SH Han et al.
ARTHRITIS AND RHEUMATISM (2005)
Genetic segregation of spontaneous erosive arthritis and generalized autoimmune disease in the BXD2 recombinant inbred strain of mice
JD Mountz et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2005)
Regeneration of the immunoglobulin heavy-chain repertoire after transient B-cell depletion with an anti-CD20 antibody
A Rouziere et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis
ED Ferucci et al.
ARTHRITIS AND RHEUMATISM (2005)
B cells as therapeutic targets for rheumatic diseases
RJ Looney et al.
CURRENT OPINION IN RHEUMATOLOGY (2004)
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
JCW Edwards et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Development of autoantibodies before the clinical onset of systemic lupus erythematosus
MR Arbuckle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis
S Rantapää-Dahlqvist et al.
ARTHRITIS AND RHEUMATISM (2003)
Hyper-IgM syndrome with putative dominant negative mutation in activation-induced cytidine deaminase
Y Kasahara et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2003)
Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis
G Cambridge et al.
ARTHRITIS AND RHEUMATISM (2003)
Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora
S Fagarasan et al.
SCIENCE (2002)
The activation-induced deaminase functions in a postcleavage step of the somatic hypermutation process
FN Papavasiliou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells
MJ Herold et al.
JOURNAL OF IMMUNOLOGY (2002)
Signals that initiate somatic hypermutation of B cells in vitro
S Bergthorsdottir et al.
JOURNAL OF IMMUNOLOGY (2001)
Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme
M Muramatsu et al.
CELL (2000)
Share Paper
